Dawnrays Pharmaceutical (Holdings) Limited's latest marketcap:
As of 07/05/2025, Dawnrays Pharmaceutical (Holdings) Limited's market capitalization has reached $237.31 M. According to our data, Dawnrays Pharmaceutical (Holdings) Limited is the 19176th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 237.31 M |
| Revenue (ttm) | 143.68 M |
| Net Income (ttm) | 76.56 M |
| Shares Out | 1.5 B |
| EPS (ttm) | 0.05 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 05/27/2025 |
| Earnings Date | 08/22/2025 |
Dawnrays Pharmaceutical (Holdings) Limited's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | HK$237.31 M | 1.71% | 19176 |
| 12/31/2024 | HK$1.83 B | 16.32% | 17951 |
| 12/29/2023 | HK$1.58 B | -20.97% | 18768 |
| 12/30/2022 | HK$1.99 B | -20.34% | 16587 |
| 12/31/2021 | HK$2.5 B | 18.77% | 16063 |
| 12/31/2020 | HK$2.11 B | -5.13% | 15101 |
| 12/31/2019 | HK$2.22 B | -4.77% | 13012 |
| 12/31/2018 | HK$2.33 B | -31.15% | 11844 |
| 12/29/2017 | HK$3.39 B | -9.27% | 11131 |
| 12/30/2016 | HK$3.73 B | -22.91% | 9611 |
Company Profile
About Dawnrays Pharmaceutical (Holdings) Limited
Dawnrays Pharmaceutical (Holdings) Limited is an investment holding company specializing in the development, manufacturing, and sale of non-patented pharmaceutical medicines. The company operates primarily in Mainland China and internationally.
Business Segments
The company operates through two key segments:
- Intermediates and Bulk Medicines
- Finished Drugs
Product Offerings
Dawnrays Pharmaceutical provides a diverse range of pharmaceutical products, including:
- Antibiotics: Pharmaceutical intermediates, bulk medicines, powder for injections, and oral antibiotics.
- System-Specific Medicines:
- Cardiovascular systems
- Anti-allergic, anti-HBV, and digestive systems
- Urinary systems
- Anti-pyretic analgesic, respiratory, and endocrine system drugs
These products are available in various forms, including tablets, capsules, and granules.
Company Background
Founded in 1995, Dawnrays Pharmaceutical (Holdings) Limited is headquartered in Wan Chai, Hong Kong.
Frequently Asked Questions
-
What is Dawnrays Pharmaceutical (Holdings) Limited's (HKG-2348) current market cap?As of 07/05/2025, Dawnrays Pharmaceutical (Holdings) Limited (including the parent company, if applicable) has an estimated market capitalization of $237.31 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Dawnrays Pharmaceutical (Holdings) Limited (HKG-2348) rank globally by market cap?Dawnrays Pharmaceutical (Holdings) Limited global market capitalization ranking is approximately 19176 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.